Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2022 Mar 18;52(2):231–235. doi: 10.1007/s11055-022-01229-z

Psychoemotional Disorders and Sleep Impairments in Patients with COVID-19

M A Samushiya 1,✉, S M Kryzhanovsky 1, A A Ragimova 1,2, T Z Berishvili 1, S A Chorbinskaya 1, E I Ivannikova 1
PMCID: PMC8930481  PMID: 35317267

Abstract

Objectives. To study the prevalence of anxious-depressive disorders and sleep impairments in their structure among patients hospitalized with the new coronavirus infections (COVID-19) and to develop differential guidelines for their treatment in COVID-19 patients. Materials and methods. This report presents preliminary results from our own observations. We report here analysis of data from 119 patients (age 47–69 years, male and female) obtained at detailed interviews, including using telemedicine technologies, with evaluation on the following scales: the Hospital Anxiety and Depression Scale (HADS), the Multidimensional Fatigue Inventory (MFI-20) for subjective assessment of asthenia, and the Pittsburgh Sleep Quality Index (PSQI). Results. Results on the HADS indicated that clinically severe anxious-depressive symptomatology was seen in 33 of 119 patients (28%) hospitalized with diagnoses of COVID-19: of these, 11% of cases (n = 13) showed clinical signs of significant anxiety only, while five (4%) showed clinically significant depression and 13% displayed increases on both the anxiety and depression subscales (n = 15). Increases on the MFI-20 scale (>20 points) were seen in 87 patients (73%) and sleep impairments on the PSQI were recorded in 32 patients (27%). Conclusions. The results of this study showed that most patients with COVID-19 had not only depressive symptomatology, but also anxious and hypochondriac disorders, asthenic symptom complex, and sleep impairments with difficulty going to sleep and poor sleep quality. Differential guidelines were developed for the treatment of these states taking account of the side effects of the drugs prescribed, interactions between drugs, and the features of the patients’ somatic condition. Drug selection must be based on the severity of the impairments found.

Keywords: COVID-19, anxious-depressive disorders, depression, asthenic syndrome, sleep impairment

Footnotes

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 121, No. 4, Iss. 2, Insomnia, pp. 49–54, April, 2021.

References

  • 1.T. Luhby, CNN, https://edition.cnn.com/2020/04/16/health/anti-anxiety-medication-us-demand-coronavirus/index.html, publ. online April 16, 2020, acc. March 2, 2021.
  • 2.Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395(10227):912–920. doi: 10.1016/S0140-6736(20)30460-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Galea S, Merchant RM, Lurie N. The mental health consequences of COVID-19 and physical distancing: the need for prevention and early intervention. JAMA Intern. Med. 2020;180(6):817–818. doi: 10.1001/jamainternmed.2020.1562. [DOI] [PubMed] [Google Scholar]
  • 4.COVID-19 and Mental Health: What We Are Learning fromwww.mhascreening.org, July 1, 2020.
  • 5.Sher L. COVID-19, anxiety, sleep disturbances and suicide. Sleep Med. 2020;70:124. doi: 10.1016/j.sleep.2020.04.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang C, Yang L, Liu S, et al. Survey of insomnia and related social psychological factors among medical staff involved in the 2019 novel coronavirus disease outbreak. Front. Psychiatry. 2020;11:306. doi: 10.2139/ssrn.3542175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cellini N, Canale N, Mioni G, Costa S. Changes in sleep pattern, sense of time and digital media use during COVID-19 lock down in Italy. J. Sleep Res. 2020;29(4):e13074. doi: 10.31234/osf.io/284mr. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Altena E, Baglioni C, Espie CA, et al. Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. J. Sleep Res. 2020;29(4):e13052. doi: 10.1111/jsr.13052. [DOI] [PubMed] [Google Scholar]
  • 9.Asmundson GJG, Taylor S. Coronaphobia: Fear and the 2019-nCoV outbreak. J. Anxiety Disord. 2020;70:102196. doi: 10.1016/j.janxdis.2020.102196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Arora A, Jha AK, Alat P, Das SS. Understanding coronaphobia. Asian J. Psychiatr. 2020;54:102384. doi: 10.1016/j.ajp.2020.102384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dubey S, Biswas P, Ghosh R, et al. Psychosocial impact of COVID-19. Diabetes Nutr. Metab. 2020;14(5):779–788. doi: 10.1016/j.dsx.2020.05.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lee SA, Jobe MC, Mathis AA, Gibbons JA. Incremental validity of coronaphobia: Coronavirus anxiety explains depression, generalized anxiety, and death anxiety. J. Anxiety Disord. 2020;74:102268. doi: 10.1016/j.janxdis.2020.102268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lee SA, Mathis AA, Jobe MC, Pappalardo EA. Clinically significant fear and anxiety of COVID-19: A psychometric examination of the Coronavirus Anxiety Scale. Psychiatry Res. 2020;290:113112. doi: 10.1016/j.psychres.2020.113112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sun QM, Qin QS, Chen BX, et al. Stress, anxiety, depression and insomnia in adults outside Hubei province during the COVID-19 pandemic. Zhonghua Yi Xue Za Zhi. 2020;100(43):3419–3424. doi: 10.3760/cma.j.cn112137-20200302-00557. [DOI] [PubMed] [Google Scholar]
  • 15.Naguy A, Moodliar-Rensburg S, Alamiri B. Coronaphobia and chronophobia – A psychiatric perspective. Asian J. Psychiatr. 2020;51:102050. doi: 10.1016/j.ajp.2020.102050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.M. Casagrande, F. Favieri, R. Tambelli, and G. Forte, “The enemy who sealed the world: Effects quarantine due to the COVID-19 on sleep quality, anxiety, and psychological distress in the Italian population,” Sleep Med. (2020), 10.1016/j.sleep.2020.05.011. [DOI] [PMC free article] [PubMed]
  • 17.Mazza C, Ricci E, Biondi S, et al. A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: Immediate psychological responses and associated factors. Int. J. Environ. Res. Public Health. 2020;17(9):3165. doi: 10.3390/ijerph17093165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Romito F, Dellino M, Loseto G, et al. Psychological distress in outpatients with lymphoma during the COVID-19 pandemic. Front. Oncol. 2020;10:1270. doi: 10.3389/fonc.2020.01270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020;288:112954. doi: 10.1016/j.psychres.2020.112954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zheng L, Miao M, Lim J, et al. Is lockdown bad for social anxiety in COVID-19 regions?: A national study in the SOR perspective. Int. J. Environ. Res. Public Health. 2020;17(12):4561. doi: 10.3390/ijerph17124561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Li X, Lu P, Hu L, et al. Factors associated with mental health results among workers with income losses exposed to COVID-19 in China. Int. J. Environ. Res. Public Health. 2020;17(15):5627. doi: 10.3390/ijerph17155627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bäuerle A, Teufel M, Musche V, et al. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J. Public Health (Oxford, England) 2020;42(4):672–678. doi: 10.1093/pubmed/fdaa106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hetkamp M, Schweda A, Bäuerle A, et al. Sleep disturbances, fear, and generalized anxiety during the COVID-19 shut down phase in Germany: relation to infection rates, deaths, and German stock index DAX. Sleep Med. 2020;75:350–353. doi: 10.1016/j.sleep.2020.08.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gennaro Mazza M, De Lorenzo R, Conte C, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav. Immun. 2020;89:594–600. doi: 10.1016/j.bbi.2020.07.037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Cai X, Hu X, Otte EI, et al. Psychological distress and its correlates among COVID-19 survivors during early convalescence across age groups. Am. J. Clin. Geriatr. Psychiatry. 2020;10:1030–1039. doi: 10.1016/j.jagp.2020.07.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Chen F, Wang XD, Zhu KK, Hu JB. Investigation of the psychological status of suspected patients during the Coronavirus disease 2019 epidemic. Medicine (Baltimore) 2020;99(38):e22260. doi: 10.1097/MD.0000000000022260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Zhang WR, Wang K, Yin L, et al. Mental health and psychosocial problems of medical health workers during the COVID-19 epidemic in China. Psychother. Psychosom. 2020;89(4):242–250. doi: 10.1159/000507639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bilbul M, Paparone P, Kim AM, et al. Psychopharmacology of COVID-19. Psychosomatics. 2020;61(5):411–427. doi: 10.1016/j.psym.2020.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Chatterjee SS, Malathesh BC, Das S, Singh OP. Interactions of recommended COVID-19 drugs with commonly used psychotropics. Asian J. Psychiatr. 2020;52:102173. doi: 10.1016/j.ajp.2020.102173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.E. G. Kostyukova, D. I. Malin, S. N. Mosolov, and E. E. Tsukarzi, “Drug therapy in patients with mental disorders and coronavirus infection (COVID-19),” Bulletin from the Serbskii National Medical Research Center for Psychiatry and Narcology, https://psychiatr.ru/download/4702?view=1&name=%D0%BB%D0%B5%D1%87%D0%B5%D0%BD%D0%B8%D0%B5.pdf.
  • 31.DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med. 2000;160(14):2101–2107. doi: 10.1001/archinte.160.14.2101. [DOI] [PubMed] [Google Scholar]

Articles from Neuroscience and Behavioral Physiology are provided here courtesy of Nature Publishing Group

RESOURCES